Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Ras association domain family 1A Promoter Methylation and Esophageal Squamous Cell Carcinoma: a Meta-analysis

  • Yang, Jian-Zhou (School of Public Health, Central South University) ;
  • Ji, Ai-Fang (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College) ;
  • Wang, Jin-Sheng (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College) ;
  • Chen, Zhong-Yi (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College) ;
  • Wen, Shi Wu (School of Public Health, Central South University)
  • Published : 2014.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

RASSF1A has been reported to be a candidate tumor suppressor in esophageal squamous cell carcinoma (ESCC). However, the association between RASSF1A promoter methylation and ESCC remains unclear. Eligible studies were identified through searching PubMed, Medline, Web of Science, and the China National Knowledge Infrastucture database. Studies were pooled and odds ratios (ORs) with corresponding confidence intervals (CIs) were calculated. Funnel plots were also performed to evaluate publication bias. Twelve studies involving 859 cases and 675 controls were included in this meta-analysis. A significant association was observed between RASSF1A methylation and ESCC overall (OR = 11.7, 95% CI: 6.59-20.9, z=8.36, P<0.00001). Subgroup analysis showed that the OR for heterogeneous tissues was 5.35 (95% CI = 2.95-9.71) while for autologous tissues it was 16.0 (8.31-30.96). For patient sample size, the OR for the <50 subgroup was 9.92 (95% CI = 2.88-34.2) and for the 50 case group was 13.1 (95% CI = 6.59-25.91). The OR for a relationship between RASSF1A methylation and TNM stages was 0.27 (95% CI=0.10-0.77), whereas there were no significant differences in RASSF1A methylation in relation to gender and differentiation among ESCC cases. This meta-analysis suggests a significant association between RASSF1A methylation and ESCC.

Keywords

References

  1. Agathanggelou A, Cooper WN, Latif F (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res, 65, 3497-508. https://doi.org/10.1158/0008-5472.CAN-04-4088
  2. Bondurant AE, Huang Z, Whitaker RS, Simel LR, Berchuck A (2011). Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer. Gynecol Oncol, 123, 581-7. https://doi.org/10.1016/j.ygyno.2011.08.029
  3. Chen J, Huang ZJ, Duan YQ, Xiao XR, Jiang JQ, et al (2012). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 5303-6. https://doi.org/10.7314/APJCP.2012.13.10.5303
  4. Cong DG, Wang SF (2007). Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof. Zhonghua Yi Xue Za Zhi, 87, 2932-4.
  5. Ding S, Wu D, Zhou J, et al. (2007). Hypermthylation Status of RASSF1A Gene Promoter Region in Esophageal Squamous Cell Carcinoma. Chin J Min Inv Surg, 7, 1213-6.
  6. Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  7. Fiolka R, Zubor P, Janusicova V, et al (2013). Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep, 30, 2878-86. https://doi.org/10.3892/or.2013.2752
  8. Ge YZ, Xu LW, Jia RP, et al (2013). The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Tumour Biol. Doi 10.1007/s13277-013-1515-3.
  9. He XY, Mao JS, Yi HX, Wu DL (2010). Relationship between RASSF1A expression and promoter methylation of RASSF1A gene in esophageal carcinoma. Modern Practical Medicine, 22, 1089-91.
  10. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
  11. Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  12. Jiang Y, Cui L, Chen WD, Shen SH, Ding LD (2012). The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS One, 7, e36780. https://doi.org/10.1371/journal.pone.0036780
  13. Kuroki T, Trapasso F, Yendamuri S, et al (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res, 63, 3724-8.
  14. Lam KY (2000) Molecular biology of esophageal squamous cell carcinoma. Crti Rev Oncol Hematol, 33, 71-90. https://doi.org/10.1016/S1040-8428(99)00054-2
  15. Li B, Wang B, Niu LJ, Jiang L, Qiu CC (2011). Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma. Epigenetics, 6, 307-16. https://doi.org/10.4161/epi.6.3.14182
  16. Li Y, Zhu CL, Nie CJ, et al (2013). Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma. PLoS One, 8, e60027. https://doi.org/10.1371/journal.pone.0060027
  17. Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Asian Pac J Cancer Prev, 14, 3719-24. https://doi.org/10.7314/APJCP.2013.14.6.3719
  18. Ma J, Yu X, Guo L, Lu SH (2013). DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma.Oncol Lett, 6, 1624-30. https://doi.org/10.3892/ol.2013.1605
  19. Mao WM, Li P, Zheng QQ, et al (2011). Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Arch Med Res, 42, 182-8. https://doi.org/10.1016/j.arcmed.2011.04.002
  20. Pan QF, Li WT, Dong HC, et al (2013). PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma. Dis Esophagus, doi: 10.1111/dote.12106.
  21. Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153.6. https://doi.org/10.1002/ijc.1440
  22. Pfeifer GP, Dammann R (2005). Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors. Biochemistry (Moscow), 70, 576-83. https://doi.org/10.1007/s10541-005-0151-y
  23. Qin Y, Wang L, Chang Z, et al (2009). RASSF1A methylation detection in esophageal cancer tissue and matched peripheral blood from the same patients. Chin J Cancer Prev Treat, 16, 359-61.
  24. Ren T, Hu JM, Liu CX, et al (2009). Study on the correlation between methylation of RASSF1A gene in Hazakh's esophageal squamous cell carcinomas. J Nongken Medicine, 31, 481-6.
  25. Su Y, Yin L, Liu R, et al (2014). Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. Med Oncol, 31, 784. https://doi.org/10.1007/s12032-013-0784-4
  26. Taghavi N, Biramijamal F, Sotoudeh M, et al (2010). p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer, 10, 138. https://doi.org/10.1186/1471-2407-10-138
  27. Teodoridis JM, Hall J, Marsh S, Kannall HD, Smyth C (2005). CpG islandmethylation of DNA damage response genes in advanced ovarian cancer. Cancer Res, 65, 8961-7. https://doi.org/10.1158/0008-5472.CAN-05-1187
  28. Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8. https://doi.org/10.7314/APJCP.2013.14.12.7713
  29. Wang CC, Mao WM, Ling ZQ (2012). DNA methylation of E-cadherin and Ras association domain family 1A in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma. Chin J Exp Surg, 29, 475-7.
  30. Wong ML, Tao Q, Fu L, et al (2006). Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol, 28, 767-73.
  31. Yamaguchi S, Kato H, Miyazaki T, et al (2005). RASSF1A gene promoter methylation in esophageal cancer specimens. Dis Esophagus, 18, 253-6. https://doi.org/10.1111/j.1442-2050.2005.00501.x
  32. Zhang Y, Wang L, Wu H, et al (2007). Promoter methylation of RASSF1A gene in esophageal tissue. J Zhengzhou University (Medical Sciences), 42, 411-4.
  33. Zhou SL, Cui J, Fan ZM, et al (2013). Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. BMC Cancer, 25, 259.

Cited by

  1. Clinical Observation and Therapeutic Evaluation of Rh-endostatin Combined with DP Regimen in Treating Patients with Advanced Esophageal Cancer vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6565
  2. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0557-y